Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance

Table 4 Areas under the receiver operating characteristic (ROC) curves for each evaluated variable in predicting homeostatic model assessment

	Men	Women
Lipid measures
TC	0.558 (0.539-0.578)	0.566 (0.547-0.584)
TG	0.657 (0.638-0.675)	0.662 (0.645-0.679)
LDL-C	0.538 (0.519-0.558)	0.550 (0.532-0.569)
Non-HDL-C	0.606 (0.587-0.625)	0.602 (0.584-0.619)
Apo B	0.596 (0.577-0.615)	0.608 (0.590-0.627)
HDL-C	0.376 (0.357-0.395)	0.402 (0.384-0.420)
Apo A-I	0.427 (0.408-0.446)	0.471 (0.453-0.490)
Lipid ratios
TC/HDL-C	0.568 (0.549-0.578)	0.576 (0.557-0.584)
TG/HDL-C	0.665 (0.647-0.684)	0.664 (0.647-0.681)
LDL-C/HDL-C	0.611 (0.592-0.630)	0.606 (0.588-0.624)
Non- HDL-C/HDL-C	0.646 (0.627-0.664)	0.632 (0.615-0.650)
Apo B/apo A-I	0.625 (0.606-0.644)	0.613 (0.595-0.631)
Visceral adiposity indicators
LAP	0.671 (0.652-0.689)	0.666 (0.649-0.684)
VAI	0.695 (0.677-0.713)	0.682 (0.665-0.699)
TyG	0.709 (0.692-0.726)	0.711 (0.695-0.728)

TC, total cholesterol; TG: triglycerides; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; Apo B: apolipoprotein B; Apo A-I: apolipoprotein A1; LAP: lipid accumulation product; VAI: visceral adiposity index; TyG index: the product of triglycerides and fasting glucose.

ISSN: 1475-2840